Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55,574,229
-
Total 13F shares
-
2,520,414
-
Share change
-
+196,515
-
Total reported value
-
$537,462,595
-
Price per share
-
$213.24
-
Number of holders
-
21
-
Value change
-
+$42,054,238
-
Number of buys
-
14
-
Number of sells
-
8
Institutional Holders of Ascendis Pharma A/S - ADR (ASND) as of Q4 2025
As of 31 Dec 2025,
Ascendis Pharma A/S - ADR (ASND) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,520,414 shares.
The largest 10 holders included
MASSACHUSETTS FINANCIAL SERVICES CO /MA/, Aberdeen Group plc, Allspring Global Investments Holdings, LLC, BRAUN STACEY ASSOCIATES INC, DIVERSIFIED TRUST CO, HARBOR CAPITAL ADVISORS, INC., SG Americas Securities, LLC, Gilbert & Cook, Inc., Avior Wealth Management, LLC, and TOTH FINANCIAL ADVISORY CORP.
This page lists
21
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.